A double-blind and placebo-controlled study of omadacycline assessing pharmacokinetic (PK) in healthy volunteers.

Trial Profile

A double-blind and placebo-controlled study of omadacycline assessing pharmacokinetic (PK) in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 May 2016

At a glance

  • Drugs Omadacycline (Primary)
  • Indications Community-acquired pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 May 2016 New trial record
    • 12 Apr 2016 Results of this and other trial (see profile 271391) assessing an effect of age and gender on the pharmacokinetics presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top